NIH Announces New Program to Develop Therapeutics for Rare and Neglected Diseases – 2
Narrator: This is NIH Health Matters. The National Institutes of Health is launching a new drug development pipeline.
Dr. Guttmacher: There exists a gap today between the early part of the scientific research needed to develop drugs to the clinical trials that are eventually done.
Narrator: Dr. Alan Guttmacher, at the National Human Genome Research Institute, says only if preclinical work is successful can a potential treatment move to clinical trials in patients. Unfortunately, the pre-clinical process is expensive and lengthy.
Dr. Guttmacher: Itís referred to in the pharmaceutical industry as the Valley of Death, because itís where many promising new drugs go to die.
Narrator: The new program specifically intends to stimulate research collaborations. For details, visit www.nih.gov. Health Matters is produced by the National Institutes of Health, part of the US Department of Health and Human Services.
About NIH Radio
NIH Radio offers free audio news programs from the National Institutes of Health, your reliable source for health information.
All NIH Radio content is in the public domain and can be used without charge or restriction provided that it is not used to misrepresent our agency nor used to suggest we endorse any private organization, product, or service.
NIH Radio is a service of the Office of Communications & Public Liaison.